ARD podcast-logo

ARD podcast

Health & Wellness Podcasts >

More Information

Location:

United Kingdom

Twitter:

@ARD_BMJ

Language:

English


Episodes

Similar performance of Humira and BI695501 biosimilar in active rheumatoid arthritis

3/28/2018
More
The switch from Humira to BI 695501 had no impact on efficacy, safety and immunogenicity in patients with moderately to severely active rheumatoid arthritis, according to a study recently published by ARD and discussed in this short podcast. Professor Stanley Cohen (Metroplex Clinical Research Center, Dallas, Texas, USA) tells ARD’s social media advisor Elena Nikiphorou (clinical researcher at King’s College London, UK) how the conclusions should have an important economic impact,...

Duration:00:15:37

Patient and doctor discordance may reduce chances of remission in rheumatoid and psoriatic arthritis

1/31/2018
More
Discordance between patient's and physician's evaluation of disease activity may reduce likelihood of remission in rheumatoid arthritis and psoriatic arthritis. Dr Paul Studenic, Austria, is joined by Dr Brigitte Michelsen and Prof Tore Kvien, both from the department of Rheumatology at the Diakonhjemmet Hospital in Oslo, Norway, to discuss their study "Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of...

Duration:00:09:13

Johannes Bijlsma

7/3/2014
More
Johannes Bijlsma is an Associate Editor on ARD and in this podcast he explains his role in the journal. He also talks through the EULAR textbook and online course in his capacity as education officer, and the new markets for rheumatology as treasurer for EULAR.

Duration:00:03:06